Clinical Trials Directory

Trials / Completed

CompletedNCT05223842

Family Promoting Positive Emotions Pilot Study

Targeting Positive Emotions to Prevent Emotional Disturbances in Children During COVID-19

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
74 (actual)
Sponsor
Vanderbilt University · Academic / Other
Sex
All
Age
8 Years
Healthy volunteers
Not accepted

Summary

Anhedonia is characterized by loss of interest or pleasure. The proposed pilot study would be the first to test an innovative, neuroscience-informed intervention in mothers reporting depressive symptoms and stress to enhance positive emotionality with the goal of preventing anhedonia and associated emotional disturbances in their children. This study will recruit dyads (mothers and their children) for the intervention.

Detailed description

Anhedonia, characterized by loss of interest or pleasure, is a primary symptom of depression. Depression is increasingly prevalent and can cause significant impairments in life functioning. Given the increased presence of stress during COVID-19, there is a significant need for interventions that can prevent the development of anhedonia and depression. This study examines a neuroscience-informed positive emotion intervention to determine its effects on preventing anhedonia and associated emotional disturbances in dyads of children and their mothers. Participants will be randomized to either receive the positive emotion intervention for 8 sessions for 8 weeks with a clinician or the self-administered written information condition. Depressive symptoms, anhedonia, stress and other internalizing disorders will be assessed at baseline, and at the end of the intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFamily Promoting Positive Emotions (F-PPE)F-PPE is an 8-session dyadic intervention designed to enhance positive emotionality and buffer against the effects of stress on anhedonia in children. The intervention will be administered online through videoconferencing sessions with a clinician to mothers and their children.
BEHAVIORALWritten InformationMothers assigned to the Written Information condition will receive email newsletters providing resources relevant to depression.

Timeline

Start date
2021-12-01
Primary completion
2023-01-20
Completion
2023-01-20
First posted
2022-02-04
Last updated
2023-02-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05223842. Inclusion in this directory is not an endorsement.